Application of topical peloid-derived humic acid suppresses allergic contact dermatitis
Key Findings
- Topical peloid-derived humic acid (HA) suppressed DNCB-induced allergic contact dermatitis (ACD) in mice
- HA reduced serum histamine levels in ACD mice
- HA suppressed DNCB-induced expression of IFN-γ, IL-4, IL-10, IL-13, IL-17, and TNF-α in ACD tissue
- HA inhibits inflammatory cell infiltration and production of inflammatory cytokines in skin
- HA treatment results in anti-inflammatory effects capable of inhibiting ACD by inducing immunosuppressive responses
- Authors conclude HA is a promising therapeutic for ACD with relevance to broad range of allergic and inflammatory skin diseases
Conference abstract (poster P120) demonstrating that topical peloid-derived humic acid suppresses allergic contact dermatitis in a DNCB-induced mouse model. HA significantly inhibited multiple inflammatory cytokines (IFN-γ, IL-4, IL-10, IL-13, IL-17, TNF-α) and reduced serum histamine. The broad cytokine suppression profile suggests HA acts via immunosuppressive mechanisms rather than targeting a single pathway, making it potentially relevant to multiple allergic and inflammatory skin conditions. Author attribution based on referenced works (Zhernov et al. 2017, Avvakumova et al. 2018); exact author list may include additional co-authors.
Where this source is used on this site
Each page below cites this paper as evidence for a specific claim. The note shows what the page draws from it.
Topical peloid-derived HA suppressed DNCB-induced ACD in mice; broad cytokine suppression
Topical peloid-derived HA suppressed IFN-γ, IL-4, IL-10, IL-13, IL-17, TNF-α in DNCB-induced ACD mice; reduced serum histamine
Topical peloid-derived HA suppressed IFN-γ, IL-4, IL-10, IL-13, IL-17, TNF-α in ACD mice